NJ Judge Tailors Evidence In Novartis Bone Drug Mass Tort

Law360, New York (April 8, 2013, 5:33 PM EDT) -- Novartis Pharmaceutical Corp. on Friday was able to limit certain expert testimony for a Mississippi woman claiming its bone cancer drug Zometa caused osteonecrosis of her jaw, but a New Jersey judge overseeing the case refused to exclude other opinions and evidence from a looming trial.

Last week, Middlesex County Superior Court Judge Jessica R. Mayer issued orders tackling three motions in limine from Novartis and one from plaintiff Beverly Meng, whose case in multicounty litigation in New Jersey over the company's Aredia and Zometa bone...
To view the full article, register now.